| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |